Press Release · Press Releases
Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance
Results from operations for third quarter 2026 versus third quarter 2025:Revenue: $3.81 billion vs. $3.56 billion, up 6.9% Diluted EPS: $3.22 vs. $3.12, up 3.3% Adjusted EPS: $4.78 vs. $4.18, up 14.5% Raised full-year enterprise revenue growth and adjusted EPS guidance:Revenue growth...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
EVERSANA Expands Global Commercialization and AI-Powered HEOR Capabilities with Acquisition of U.K.-based Estima Scientific
Acquisition builds on EVERSANA's commitment to investing in transformative, technology-first companies to modernize commercialization. CHICAGO and LONDON, Oct. 28, 2026 /PRNewswire/ -- EVERSANA®, a global provider of modern, AI-powered commercial services for the biopharmaceutical...
PR Newswire ·
Identity Theft Resource Center 2026 Consumer Impact Report: Scams inflict significant trauma compared to traditional identity theft
General consumer scam victims report thoughts of suicide at more than triple the rate of traditional identity theft victims (80.5% vs. 24.5%). SAN DIEGO, Oct. 28, 2026 /PRNewswire/ -- Scams are having a major impact on people's lives in the United States, triggering acute emotional...
PR Newswire ·
McKinsey and Parloa announce alliance for customer-facing AI technology
New collaboration pairs McKinsey's deep operations expertise and advanced agentic AI capabilities with Parloa's AI Agent Management Platform to help enterprises deliver customer service with the help of AI agents. NEW YORK and BERLIN, Oct. 28, 2026 /PRNewswire/ -- Agentic CX leader Parloa...
PR Newswire ·
Genefluence's rapid, near-patient PCR test for urinary tract infections in first use at the Royal Hospital Chelsea
Test identifies UTI-causing bacteria and antibiotic resistance genes at the point of decision – helping clinicians choose the right antibiotic first time LONDON, Oct. 28, 2026 /PRNewswire/ -- Medical and consumer genetics innovator Genefluence today announces the first use of its rapid,...
PR Newswire ·
Regal Healthcare Named to Inc.'s 2026 Founder-Friendly Investors List for Fifth Consecutive Year
NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Regal Healthcare Capital Partners ("Regal") has been named to Inc.'s 2026 Founder-Friendly Investors list, which recognizes private equity firms, venture capital firms, and lenders with demonstrated track records of supporting founder-led companies....
PR Newswire ·
BRINKER INTERNATIONAL REPORTS FIRST QUARTER FISCAL 2027 RESULTS AND UPDATES FISCAL 2027 GUIDANCE
DALLAS, Oct. 28, 2026 /PRNewswire/ -- Brinker International, Inc. (NYSE: EAT) today announced its financial results for the first quarter ended September 23, 2026 and updated guidance for fiscal 2027. First Quarter Fiscal 2027 Financial Highlights "Chili's delivered its 22nd consecutive...
PR Newswire ·